The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health
Rev. saúde pública (Online); 54 (), 2020
ABSTRACT OBJECTIVES This study examined the purchases of eculizumab, a high-cost monoclonal antibody used in the treatment of rare diseases by Brazilian federal agencies, in terms of purchased quantities, expenditures, and prices. METHODS Eculizumab purchases made between March 2007 and December 2018...